Business Context and Reporting Period
Company: Pliant Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 3, 2026
Principal Executive Offices: South San Francisco, CA
This filing reports a material modification to the rights of security holders and the entry into a material definitive agreement regarding the Company's stockholder rights plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and securities structure rather than financial performance.
Material Changes
- Expiration Date Extension: The final expiration time of the Series A Junior Participating Preferred Purchase Rights was extended from 5:00 p.m. New York City time on March 11, 2026, to 5:00 p.m. New York City time on March 11, 2027.
- Agreement Amendment: An Amendment to the Stockholder Rights Agreement was executed between Pliant Therapeutics, Inc. and Computershare Trust Company, N.A. (Rights Agent).
Guidance, Outlook, and Management Commentary
Purpose of Amendment: The extension is intended to reduce the likelihood that any entity, person, or group can gain control of the Company through open market accumulation without paying all stockholders an appropriate control premium. It also aims to provide the Board sufficient opportunity to make informed judgments in the best interests of the Company and all stockholders.
Takeover Context: The Company explicitly states that the Rights Agreement was not amended in response to any specific takeover offer and is not intended to interfere with any merger or business combination approved by the Board.
Investor Verification Checklist
- Verify the full text of the Amendment to Stockholder Rights Agreement (Exhibit 4.2) for specific terms regarding redemption, exchange, or termination.
- Confirm the current status of the Series A Junior Participating Preferred Purchase Rights and their trading symbol (N/A) on The Nasdaq Stock Market LLC.
- Review the original Stockholder Rights Agreement (dated March 12, 2025) to understand the baseline terms prior to this extension.
- Monitor for any future filings indicating a specific takeover offer or change in control that might trigger the rights plan.